|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 13, Issue 3, 1083-1098, March 2002
and
*Centre for Immunology, St. Vincent's Hospital, University
of New South Wales, Sydney, New South Wales, Australia; and
Discipline of Medical Biochemistry, School of Biomedical
Sciences, Faculty of Medicine and Health Sciences, The University of
Newcastle, Callaghan, New South Wales, Australia
| |
ABSTRACT |
|---|
|
|
|---|
Mast cells undergo cytoskeletal restructuring to allow secretory granules passage through the cortical actomyosin barrier to fuse with the plasma membrane and release inflammatory mediators. Protein phosphorylation is believed to regulate these rearrangements. Although some of the protein kinases implicated in this phosphorylation are known, the relevant protein phosphatases are not. At the peak rate of antigen-induced granule mediator release (2.5 min), protein phosphatases PP1 and PP2A, along with actin and myosin II, are transiently relocated to ruffles on the apical surface and a band at the peripheral edge of the cell. This leaves an area between the nucleus and the peripheral edge significantly depleted (3-5-fold) in these proteins. Phorbol 12-myristate 13-acetate (PMA) plus A23187 induces the same changes, at a time coincident with its slower rate of secretion. Coimmunoprecipitation experiments demonstrated a significantly increased association of myosin with PP1 and PP2A at the time of peak mediator release, with levels of association decreasing by 5 min. Jasplakinolide, an inhibitor of actin assembly, inhibits secretion and the cytoskeletal rearrangements. Surprisingly, jasplakinolide also affects myosin, inducing the formation of short rods throughout the cytoplasm. Inhibition of PP2A inhibited secretion, the cytoskeletal rearrangements, and led to increased phosphorylation of the myosin heavy and light chains at protein kinase C-specific sites. These findings indicate that a dynamic actomyosin cytoskeleton, partially regulated by both PP1 and PP2A, is required for mast cell secretion.
| |
INTRODUCTION |
|---|
|
|
|---|
The cross-linking of receptor-bound IgE on the mast cell surface
triggers a sequence of intracellular events that culminate in the
extracellular release of potent inflammatory mediators, many of which
are stored in the secretory granules (Razin et al., 1995
;
Beaven and Baumgartner, 1996
). Conversely, mast cell granule mediators,
especially tumor necrosis factor-
have also been shown to
play a central role in the defense against bacterial infection (Echtenacher et al., 1996
; Malaviya et al.,
1996
). Therefore, understanding the mechanism through which mast cells
release these mediators is of broad physiological importance.
In mast cells, the proteins regulating the heterotypic fusion process
between the secretory granules and plasma membrane have been identified
as soluble N-ethylmaleimide-sensitive factor attachment protein receptor-related proteins (Guo et al., 1998
; Hibi
et al., 2000
). However, the granules in mast cells are kept
apart from their fusion sites on the plasma membrane by a cortical
cytoskeletal barrier made up predominantly of actin and myosin. How the
granules are moved toward and through this actomyosin barrier to
their fusion sites is not understood in any regulated exocytotic cell. Recent studies in a variety of secretory cells, using inhibitors of
actin or myosin function, have shown that remodeling of the actomyosin
cortex is a prerequisite for regulated exocytosis (Lang et
al., 2000
; Valentijn et al., 2000
).
Exocytosis is accompanied by distinct morphological changes that are
believed to facilitate the removal or rearrangement of the cortical
barrier (Lang et al., 2000
; Oheim and Stuhmer, 2000
; Sullivan et al., 2000
; Valentijn et al., 2000
).
In activated mast cells these include the formation of ruffles or
lamellae on the apical surface that contain both actin and myosin
(Pfeiffer et al., 1985
; Sahara et al., 1990
;
Ludowyke et al., 1994a
) and the spreading of the cells upon
the underlying substratum (Oliver et al., 1988
; Ludowyke
et al., 1994a
). Correlated with these changes are increased
assembly of F-actin (Oliver et al., 1988
; Apgar, 1991
), the
formation of focal adhesions (Kawasugi et al., 1995
), and
actin- and myosin-containing plaques and filaments on the basal surface
(Ludowyke et al., 1994b
; Pfeiffer and Oliver, 1994
).
The actomyosin cortical web is dynamic; it is rapidly
disassembled and assembled in response to extracellular signals,
controlled in part by the phosphorylation of myosin at specific sites
on the heavy and light chains (Sellers, 1991
; Bresnick, 1999
). In contrast to smooth muscle, myosin IIA is the only conventional myosin
isoform found in RBL-2H3 cells (Choi et al., 1996
). In unstimulated cells, the myosin light chain (MLC) is phosphorylated by
myosin light chain kinase (MLCK), and the myosin heavy chain (MHC) is
phosphorylated at a number of sites by unknown kinases (Ludowyke
et al., 1989
). Activation of these cells with antigen or
calcium ionophore does not affect phosphorylation at these sites, but
leads to the phosphorylation of both the heavy chains and light chains
by protein kinase C (PKC) at distinct sites (Ludowyke et
al., 1989
, 1996
; Choi et al., 1994
). Recent work has
shown that the MHC is also phosphorylated by
Ca2+/calmodulin-dependent protein kinase II (CaM
kinase II) during activation (Buxton and Adelstein, 2000
).
The balance of specific kinases and phosphatases dynamically
regulates protein phosphorylation. The serine and threonine
phosphatases are separated into two main families, defined as PPP and
PPM. The predominant members of the PPP family are protein phosphatase type 1 (PP1), PP2A, and PP2B (calcineurin), whereas PP2C is the predominant PPM protein phosphatase. PP1 and PP2A are considered the
major intracellular phosphatases, which together account for >90% of
all serine/threonine dephosphorylation reactions (Cohen, 1989
; Cohen
and Cohen, 1989
; Mumby and Walter, 1993
; Wera and Hemmings, 1995
).
Although the phosphatases that regulate myosin in mast cells are not
known, in muscle cells it is clear that the primary phosphatase
affecting the MLC is PP1 (Chisholm and Cohen, 1988
; Hartshorne et
al., 1998
). This phosphatase dephosphorylates the sites
phosphorylated by MLCK (Thr-18, Ser-19), but the phosphatases affecting
the physiologically important PKC sites on the MLC (Ser-1, Ser-2) or
the MHC (Ser-1917) are unknown. There is growing evidence, however, of
a role for phosphatases in controlling myosin function in platelets
during the massive shape changes that occur during aggregation and
secretion (Toyoda et al., 1996
; Nakai et al., 1997
). Interestingly, in these studies there was a greater association of PP2A with the cytoskeleton after stimulation than PP1, yet the
literature suggests that PP1 plays the major role in myosin dephosphorylation. In light of these findings and our recent
demonstration of the critical role of PP2A in membrane events during
mast cell secretion (Ludowyke et al., 2000
), we investigated
the association of PP1 and PP2A with the rearranging actomyosin
cytoskeleton during mast cell secretion.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell Culture, Activation, and Analysis of Secretion
Tissue culture supplies were obtained from Invitrogen
(Carlsbad, CA). Maintenance of monolayer cultures of RBL-2H3 cells was in RPMI with 10% fetal calf serum and carried out as described previously (Ludowyke et al., 1989
; Pfeiffer and Oliver,
1994
; Kawasugi et al., 1995
). Cells (1.5 × 106)/well in six-well culture dishes or 1 × 105 cells/well in eight-well chamber slides (BD
Biosciences, Franklin Lakes, NJ) were washed twice and activated at
37°C in buffer A, consisting of 119 mM NaCl, 5 mM KCl, 5.6 mM
dextrose, 0.4 mM MgCl2, and 25 mM
piperazine-N,N'-bis(2-ethanesulfonic acid); pH
7.2. Buffer A was supplemented with 0.1% bovine serum albumin (BSA) and 1 mM CaCl2 before use. For antigen
activation, cells were primed overnight with 75 ng/ml dinitrophenol
(DNP)-specific IgE (Sigma Chemical, St. Louis, MO) and activated with
100 ng/ml of the specific antigen DNP24-BSA (24 molecules of DNP
conjugated with 1 molecule of BSA, hereafter referred to as DNP-BSA;
Calbiochem-Novabiochem, La Jolla, CA). Where required, cells were
activated with 50 nM phorbol 12-myristate 13-acetate (PMA) or the
combination of 50 nM PMA and 500 nM calcium ionophore A23187 (both from
Sigma Chemical). Control samples were incubated with buffer A alone.
After the designated time, the reaction was stopped by placing the
samples on ice; the supernatant was removed and an aliquot taken for
assay of the release of
-hexosaminidase. The total cellular content of
-hexosaminidase was determined after lysis of unstimulated cultures and the activated release was expressed as a percentage of
totals. The amount of
-hexosaminidase released was assayed using an
absorbance assay with
p-nitrophenyl-N-acetyl-
-D-glucosaminide (Sigma Chemical) as the substrate (Ludowyke et al., 2000
).
When isotopic labeling of cells was required, cells were labeled with 100 µCi/ml of [32P]orthophosphoric acid
(Amersham Biosciences AB, Uppsala, Sweden) at 37°C for 2 h in
buffer A with the addition of 4 mM glutamine, as previously described
(Ludowyke et al., 1989
, 1996
). The cells were washed three
times with buffer A before activation (as described above) or addition
of inhibitors. When inhibitors were required, okadaic acid (OA;
potassium salt; Calbiochem-Novabiochem) was dissolved in buffer A and
jasplakinolide (Molecular Probes, Eugene, OR) was dissolved in dimethyl
sulfoxide. The final buffer concentration of dimethyl sulfoxide was no
>0.2%, which was added to control cells and had no effects on
secretion or morphology (Ludowyke et al., 1998
). Cells were
preincubated with the inhibitors in activation buffer containing 4 mM
glutamine at 37°C for the designated times. Washing the cells free of
excess inhibitors had no effect on the inhibitory capacity. Incubation
of cells for 45 min or 3 h in buffer alone had no effect on
morphology or secretion.
Fluorescence Microscopy
After activation in an eight-well chamber slide as
described above, cells were fixed with 200 µl of a solution
containing 3% (vol/vol) formaldehyde, 0.1% (vol/vol) gluteraldehyde,
and 0.1% Triton X-100 in phosphate-buffered saline (PBS) for 15 min at
room temperature. The wells were washed in PBS and nonspecific binding
sites were blocked with 5% (wt/vol) skim milk in PBS for 30 min. The
wells were incubated for 2 h with specific rabbit polyclonal
antibodies raised against peptides derived from the C termini of the
catalytic subunits of PP1 or PP2A (as previously defined in Sim
et al., 1998
), or against nonmuscle myosin (Biomedical Technologies, Stoughton, MA). After washing with PBS the wells were
then incubated for 60 min with the fluorescein isothiocyanate (FITC)-labeled secondary antibodies (Amersham Biosciences AB). F-actin
was primarily detected using FITC-labeled phalloidin (Sigma Chemical)
for 45 min. Alternatively, actin was detected using a monoclonal
primary antibody for 2 h followed by an FITC-labeled secondary
antibody for 60 min (both from Amersham Biosciences AB). A coverslip
was then mounted on top of antiquench reagent (90% glycerol, 10%
[vol/vol] PBS, containing 1 mg/ml p-phenylenediamine). Cells were viewed using an Olympus BX60 fluorescence microscope (Olympus, Tokyo, Japan) and Sensicam Imaging (Kelheim, Germany). Images
were collected using a 60× oil objective directly into IP Lab Gel
before final analysis in Adobe Photoshop (Adobe Systems, Mountain View,
CA). Under the same conditions, with any of the primary or secondary
antibodies alone, no signal was detected (our unpublished data).
Fluorescence Intensity Measurements
Images of immunostained cells collected directly from the microscope as described above were imported into NIH Image. For single whole cell analysis, a line was marked through the cell, starting outside the periphery at one edge, extending through the nucleus, ending outside the periphery at the opposite edge of the cell. For partial cell analysis, the line was marked from outside the peripheral edge of the cell, 10 µm into the cell (the edge of the nucleus), giving 90 point measurements. Up to three line measurements were taken from at least 10 cells from a number of different experiments, giving a total of 30 measurements. Means and SEs of the data points were used to plot the fluorescence intensity graphs. Intensity graphs show symbol and error bar at every fifth data point. To compare between the control and stimulated cells, 10 points around the peak intensity of the peripheral band or lowest points of the cytoplasmic clearance were compiled and compared with the equivalent points from unstimulated cells or cells 30 min after activation. GraphPad Prism (GraphPad Software, San Diego, CA) was used to analyze the data with a nonparametric paired t test (Wilcoxon signed rank test, two-tailed, confidence interval 95%), giving the significance data shown.
Cell Lysis for Immunoprecipitation and Western Blotting
After activation in a six-well plate as described above, 0.3 ml
of ice-cold lysis buffer (buffer B or C; see below) was added and the
cells were scraped immediately into microfuge tubes. The immunoprecipitation of myosin was carried out as previously described, using buffer B, containing 250 mM NaCl; 100 mM sodium pyrophosphate; 100 mM sodium fluoride; 10 mM EGTA; 5 mM EDTA; 25 mM Tris-HCl pH 8.5;
0.5% Nonidet P-40; 200 µM pefabloc; 20 µg/ml leupeptin, pepstatin,
and aprotinin; 10 µM DNase; and 10 µg/ml RNase (Ludowyke et
al., 1989
, 1996
). Buffer C was used for immunoprecipitation of the
phosphatases and contained 100 mM NaCl; 50 mM sodium pyrophosphate; 50 mM sodium fluoride; 2 mM sodium orthovanadate; 20 mM HEPES pH 8.8;
0.5% Nonidet P-40; 200 µM pefabloc; 20 µg/ml leupeptin, pepstatin,
and aprotinin; 10 µM DNase; and 10 µg/ml RNase (adapted from
Begum, 1995
). Monoclonal antibodies against the catalytic subunit of
PP1 (Santa Cruz Biotechnology, Santa Cruz, CA) or PP2A (Upstate
Biotechnology, Lake Placid, NY), or a polyclonal antibody against
myosin (as described above) were prebound for 2 h to protein A-Sepharose CL-4B (Amersham Biosciences AB). Immunoprecipitation results achieved with the commercial anti-myosin antibody were the same
as achieved using the well-described anti-human platelet myosin
antibody, kindly donated by Dr. Robert S. Adelstein (National Institutes of Health, Bethesda, MD) (our unpublished data), and as
previously described (Ludowyke et al., 1989
). The cell
lysates were rotated at 4°C for 12-16 h with antibody-protein
A-Sepharose beads. The lysate/bead slurry was subsequently added to
ProbeQuant G-50 microcolumns (prewashed to remove G-50 resin; Amersham
Biosciences AB) and centrifuged in screw-capped tubes at 6000 rpm for
20 s to remove unbound proteins. The beads were washed to remove
nonspecific proteins in lysis buffer, 50:50 lysis buffer/PBS, and
finally PBS. Beads were resuspended in 100 µl of Laemmli's sample
buffer and heated at 85°C for 5 min to dissociate proteins from the beads.
Western Blotting
Immunoprecipitated proteins, solubilized in Laemmli's sample buffer, were then separated on 10% SDS-polyacrylamide gels and transferred to polyvinylidene difluoride membranes at 400 mA for 2 h. The membranes were washed and nonspecific binding sites were blocked with 5% (wt/vol) skim milk in PBS. The membranes were incubated for 90 min with the polyclonal or monoclonal PP1 or PP2A primary antibodies or polyclonal myosin primary antibodies (as described above) and 60 min with the horseradish peroxidase-labeled secondary antibodies (Amersham Biosciences AB). The proteins were detected using an enhanced chemiluminescent detection kit (PerkinElmer Life Sciences, Boston, MA) following the manufacturer's instructions. As a control, incubation of the cell lysate with protein A-Sepharose beads alone, under the same conditions as described above, showed no nonspecific binding of myosin, PP1, or PP2A. For quantitation, the bands on the Amersham x-ray film were captured using a laser densitometer and analyzed using ImageQuant (Molecular Dynamics, Sunnyvale, CA). GraphPad Prism (GraphPad Software) was used to analyze the densitometric data, by using a nonparametric paired t test (two-tailed, confidence interval 95%), giving the significance data shown.
One-Dimensional Isoelectric Focusing (IEF) and Tryptic Peptide Mapping
Immunoprecipitated myosin from 32P-labeled
cells was separated by SDS-PAGE on either 12.5% gels for the light
chain, or 5% gels for the heavy chain. Gels were stained with
Coomassie blue (Bio-Rad, Hercules, CA), dried, and subjected to
autoradiography. The areas containing the
32P-labeled myosin heavy or light chains were cut
from the gel and treated as described previously (Ludowyke et
al., 1989
). Briefly, gel slices were digested overnight in a
solution containing L-1-tosylamido-2-phenylethyl chloromethyl ketone-trypsin in 50 mM
NH4HCO3, centrifuged to
remove gel slices, lyophilized, and resuspended in a final volume of 22 µl of 50 mM NH4HCO3.
Tryptic peptide mapping was conducted using a 0.5-mm-thick urea
polyacrylamide one-dimensional IEF system as previously described
(Moussavi et al., 1993
; Ludowyke et al., 1996
).
Briefly, the Biolytes (Bio-Rad) used were pH 3-5, 4-6, and 5-8
(1:1:1). The peptides were separated by electrophoresis at 25 W/1350 V
at 10°C for 35 min with 1 M NaOH as the cathode buffer and 1 M
H3PO4 as the anode buffer.
The dried gels were then subjected to autoradiography and analyzed as
for Western blotting as described above.
| |
RESULTS |
|---|
|
|
|---|
Antigen-induced Rearrangement of Cytoskeletal Proteins and Phosphatases
In unstimulated RBL-2H3 cells there are no actomyosin
microfilaments evident; however, actin and myosin are distributed
throughout the cell and localized to small microvilli on the apical
surface. After the addition of antigen to IgE-primed mast cells, large ruffles are formed on the apical surface in which both actin and myosin
become concentrated (Figure 1A, b and d).
These changes are observed at a time before or coincident with the peak
rate of granule mediator release (2.5 min poststimulation for antigen) (Pfeiffer et al., 1985
; Sahara et al., 1990
;
Ludowyke et al., 1994a
; Spudich, 1994
).
|
In unstimulated mast cells, PP1 and PP2A are broadly distributed throughout the cytoplasm and nucleus with a similar apical localization as actin and myosin (Figure 1B, a and c). Furthermore, as with myosin and actin, PP1 and PP2A become localized to the apical ruffles within 2.5 min after stimulation by antigen (Figure 1B, b and d). It is also evident that PP1 and PP2A are in the nucleus, but the levels do not change after activation (Scurr, Sewell, and Ludowyke, unpublished observations).
In addition to the formation of these surface ruffles, there are
many other changes in the morphology and cytoskeletal structure of mast
cells after stimulation. The cells decrease in height by 50% (Ludowyke
et al., 1994a
,b
) and spread out on the substrate, increasing
their surface area (Oliver et al., 1988
; Ludowyke et al., 1994b
). As shown in Figure 2A,
these changes correspond to considerable cytoskeletal rearrangements on
the basal surface of the cells. Within 2.5 min after addition of
antigen, a thick band of actin and myosin has formed at the periphery
of the spreading cells, with a corresponding clearance of these
proteins from the cytoplasm between the nucleus and cell periphery
(Figure 2A, b and e). By 30 min poststimulation, however, myosin and
actin have returned to a distribution similar to that seen in
unstimulated cells, although the actin plaques are still evident
(Figure 2A, c and f).
|
Figure 2B documents a similar pattern of redistribution of PP1 and PP2A. Within 2.5 min of the addition of antigen, both PP1 and PP2A are cleared from the cytoplasm of the spreading cell and are concentrated in a thick band around the periphery of the cell (Figure 2B, b and e). This band can be seen forming within 1 min after addition of antigen, indicating that these changes do in fact precede the peak rate of granule secretion (our unpublished data). However, within 30 min of stimulation, both PP1 and PP2A have returned to their cytoplasmic locations, with the pattern of distribution being similar to that found in unstimulated cells (Figure 2B, c and f).
To quantitate the changes in these cells, the fluorescence intensity
was analyzed. Initially, cross sections from a single cell were taken,
clearly defining the broad band of protein at the periphery of the
cell, 2.5 min after activation (Figure
3A, b). The graphs also suggest that by
30 min poststimulation, the pattern of distribution has reverted to
that of unstimulated cells (Figure 3A, a and c). To specifically
analyze the band at the cell periphery and the clearance from the
cytoplasm, fluorescence intensity data were compiled from a point
immediately outside the periphery of the cell to the edge of the
nucleus in both unstimulated and stimulated cells. These data indicate
that antigen stimulation induces a significant (p < 0.002)
twofold increase in fluorescence intensity in the band at the cell
periphery for PP1, PP2A, and myosin (Figure 3B). There is a
corresponding significant (p < 0.002) threefold decrease in
intensity approximately midway between the nucleus and cell periphery
for PP1 and PP2A and a fivefold decrease in myosin immunostaining
(Figure 3B). These data also confirm that by 30 min poststimulation,
the distribution of PP1, PP2A, and myosin have returned to that of
unstimulated cells. Actin was not analyzed as the staining was more
punctate and there was no nuclear staining to orient the line
measurements.
|
PMA Plus Calcium Ionophore A23187-induced Rearrangement of Cytoskeleton and Phosphatases
PMA plus A23187 induced secretion with a slower onset and a
delayed peak rate of secretion; 4-6 min compared with 2.5 min for
antigen (Ludowyke et al., 2000
). As seen with antigen
stimulation a peripheral accumulation of PP1 and PP2A was also observed
at the peak of PMA plus A23187-stimulated secretion (Figure
4A, b and e). The clearance of PP1 and
PP2A from the cytoplasm between the nucleus and cell periphery is
slightly more pronounced than seen with antigen (Figure 4B; 5-6-fold
decrease in fluorescence intensity; p < 0.002). Interestingly,
unlike antigen stimulation, the distribution of PP1 and PP2A does not
return to unstimulated levels 30 min after addition of PMA plus A23187
(Figure 4A, c and f). At this time, the clearance from the cytoplasm
remains significantly different from unstimulated cells (Figure 4B;
3-4-fold; p < 0.002). These results show that two separate
secretagogues with different initial modes of action and time course,
both induce a similar redistribution of PP1 and PP2A at the time of
peak granule secretion. A similar rearrangement of actin and myosin at
these time points was observed (our unpublished data).
|
The addition of PMA alone to RBL-2H3 cells does not induce
secretion, yet it does induce many of the intracellular signals generated by antigen, such as activation of PKC and a redistribution of
actin and myosin (Choi et al., 1994
; Ludowyke et
al., 1994b
, 1996
). PMA alone induces a similar rearrangement of
PP1 and PP2A as that seen with PMA plus A23187 (Figure 4A), suggesting
that these changes do not require an increase in intracellular calcium (our unpublished data).
Coimmunoprecipitation of Myosin, PP1, and PP2A
Having established that during the peak rate of granule
mediator release, PP1 and PP2A are localized in areas where myosin and
actin are also concentrated, we sought to determine whether there was
an association between these proteins. Myosin, PP1, and PP2A were
immunoprecipitated from unstimulated and antigen-stimulated RBL-2H3
cells as described in MATERIALS AND METHODS (Ludowyke et
al., 1989
, 1996
). The myosin immunocomplex was probed by Western immunoblotting for the presence of PP1c and PP2Ac. In
reciprocal analyses, PP1c or PP2Ac immunocomplexes were probed for the
presence of myosin. Because these reciprocal immunoprecipitations
investigated the association of myosin with the phosphatases, the
densitometric analyses of the Western blots were combined. Whether
myosin or the phosphatases were immunoprecipitated, relative to
unstimulated cells, there was a significant increase in the association
of myosin with both PP1c and PP2Ac at the peak rate of secretion (Figure 5). There was a 1.78-fold ± 0.25 (n = 5; p < 0.05) increase in the association of myosin
with PP1c and a 1.36-fold ± 0.04 (n = 6; p < 0.05)
increase in the association of myosin with PP2Ac. Remarkably, by 5 min
poststimulation the amount of myosin associated with both PP1c and
PP2Ac had returned to levels similar to that in unstimulated cells
(1.05 ± 0.11- and 1.09 ± 0.14-fold, respectively; Figure
5). The level of recovery of PP1, PP2A, and myosin from their
respective immunoprecipitates was the same from the control and at each
time point (our unpublished data).
|
Inhibition of Mast Cell Secretion by Inhibitors of Actin Assembly and Phosphatase Activity
To further investigate the link between cytoskeletal
rearrangements, PP1, PP2A, and secretion, we used jasplakinolide, an inhibitor of actin assembly, and OA, an inhibitor of phosphatase activity. Jasplakinolide has been shown to bind to actin, inhibiting polymerization (Bubb et al., 1994
). We have recently shown
that jasplakinolide can inhibit insulin secretion from RINm5F cells (Wilson et al., 2001
). We have found herein that
preincubation of RBL-2H3 cells for 3 h with 5 µM jasplakinolide
inhibits the antigen-induced secretion of
-hexosaminidase by 73 ± 9.4%. Under these conditions, jasplakinolide does not affect the
association of either PP1 or PP2A with myosin in unstimulated cells.
Furthermore, although jasplakinolide inhibited secretion, there was no
effect on the increased association of myosin with PP1 and PP2A, 2.5 min after antigen stimulation (Figure
6A). In addition, the association of
actin with myosin does not appear to be affected by jasplakinolide or
to change over this time period (Figure 6A). Nevertheless, in
antigen-stimulated cells, jasplakinolide prevented the clearance of
actin, PP1, and PP2A from the cytoplasm and the formation of the
characteristic band at the periphery of the cells (Figure 7, a, c, and e). However, these
cytoskeletal changes are seen in cells preincubated with buffer for
3 h and subsequently stimulated with antigen (Figure 7, b, d, and
f). Control cells incubated with jasplakinolide, without subsequent
addition of antigen, were similar to those depicted in the presence of
antigen (our unpublished data). Jasplakinolide induced some of the
cells to become round; however, there were few other effects of
jasplakinolide upon the distribution of actin, whether investigated
using a monoclonal anti-actin antibody or phalloidin (our unpublished
data).
|
|
Surprisingly, there was a very clear alteration in the distribution of myosin after the addition of jasplakinolide. Jasplakinolide induced myosin to form short, rod-like structures throughout the cell (highlighted in a magnified view in Figure 7g, ii). These structures remained after antigen stimulation and there was no clearance from the cytoplasm or formation of the peripheral band. Interestingly, jasplakinolide did not affect the association of myosin with PP1, PP2A, or actin, before or after stimulation (Figure 6A). These data suggest that antigen-mediated PP1 and PP2A redistribution is dependent upon an intact actomyosin microfilament system, which is also required for secretion in these cells.
Addition of the PP1 and PP2A inhibitor OA to RBL-2H3 cells inhibited
secretion (Kitani et al., 1996
; Ludowyke et al.,
1998
); however, we have shown that the addition of 1 µM OA for 45 min only inhibits the activity of PP2A (Ludowyke et al., 2000
).
In the present experiments using the same conditions, OA inhibited the
antigen-induced secretion of
-hexosaminidase by 74 ± 4%, a
similar amount to that of jasplakinolide.
Analysis of myosin immunoprecipitates revealed that the addition of OA
inhibited the association of PP1 and PP2A with myosin in unstimulated
cells by ~50% (our unpublished data). Furthermore, where previously
the association of PP2A with myosin increased 2.5 min after antigen
stimulation (Figure 5B), OA pretreatment led to a decreased association
at this time point (Figure 6B). PP1 was not detected in association
with myosin after OA pretreatment, although it was clearly evident
after immunoblotting the unbound proteins (our
unpublished data). There was no apparent change in the amount of actin
associated with myosin over this time course (Figure 6B). Consistent
with these findings, immunofluorescence images showed that OA clearly
disrupts the antigen-stimulated rearrangement of actin and myosin.
After preincubation with OA, the cells became round and the addition of
antigen did not induce any cytoskeletal alterations. That is, there was
no formation of the characteristic band surrounding the periphery of
the cells or clearance of actin, myosin, PP1, and PP2A from the
cytoplasm (Figure 8, a, c, e, and g).
However, these cytoskeletal changes are seen in cells preincubated with
buffer and subsequently stimulated with antigen (Figure 8, b, d, f, and
h). Control cells preincubated with OA without subsequent addition of
antigen were similar to those depicted herein in the presence of
antigen (our unpublished data).
|
Inhibition of Phosphatase Activity Leads to Increased MHC and MLC Phosphorylation at PKC-specific Sites
Having previously established that preincubation of RBL-2H3 cells
with OA (1 µM for 45 min) inhibited the activity of PP2A and not that
of PP1 (Ludowyke et al., 2000
), our present data implied
that the cytoskeletal changes we observed herein may also be regulated
more by PP2A than PP1. To further investigate this, we added 1 µM OA
to cells that had been prelabeled with 32P to
label intracellular pools of ATP and then immunoprecipitated myosin as
described in MATERIALS AND METHODS. Both the 200-kDa MHC and the 20-kDa
MLC are phosphorylated in unstimulated cells and the level of
phosphorylation increases when the cells are stimulated by antigen or
PMA (Figure 9A; Ludowyke et
al., 1989
, 1996
; Choi et al., 1994
). We demonstrate
herein that the addition of OA also leads to a time-dependent increase
in the phosphorylation of the MHCs and MLCs (Figure 9A). The MHCs and
MLCs were excised from the gels, trypsinized, lyophilized, and the
tryptic peptides separated by one-dimensional IEF as previously
described (Ludowyke et al., 1996
). The peptide map of the
MHC shows a number of phosphopeptides in control cells (Figure 9B). The
addition of OA leads to the time-dependent generation of another
phosphopeptide separating toward the cathode. Although increased
phosphorylation is seen in other peptides, this particular
phosphopeptide matches the MHC phosphopeptide generated after the
addition of PMA to Jurkat cells and antigen to RBL-2H3 cells (Ludowyke
et al., 1989
; Moussavi et al., 1993
) and is known
to contain the PKC phosphorylation site Ser-1917 (Conti et
al., 1991
).
|
The peptide map of the MLC shows a single phosphopeptide in control
cells, previously established as the Ser-19 site that is phosphorylated
by MLCK. As we have previously demonstrated, the addition of antigen or
PMA leads to the phosphorylation of another site, Ser-1 or Ser-2, that
is known to be phosphorylated by PKC (Ludowyke et al., 1989
,
1996
). The addition of OA induced a time-dependent increase in
phosphorylation of these PKC-specific sites (Figure 9C). Although in
some experiments there was a small increase in the phosphorylation at
the MLCK and Di-MLCK (Thr-18/Ser-19) sites, the predominant effect of
the addition of OA was an increased phosphorylation at the PKC sites.
The two MLC peptides attributed to phosphorylation by PKC (PKC and
PKC') both correspond to Ser-1 or Ser-2, but the upper band is
generated by further tryptic cleavage of the arginine residue from the
sequence Ser-Ser-Lys-Arg (Nakabayashi et al., 1991
; Moussavi
et al., 1993
).
Therefore, the addition of OA to RBL-2H3 cells time dependently inhibits the activity of PP2A and leads to increased phosphorylation of the MHC and MLC at sites known to be phosphorylated specifically by PKC.
| |
DISCUSSION |
|---|
|
|
|---|
Regulated exocytosis requires the remodeling of the cortical actomyosin barrier, allowing granules access to their fusion sites to release their contents into the extracellular space. In mast cells, the kinetics of this remodeling correlates with the increased phosphorylation of myosin on both its heavy and light chains, at serine and threonine sites. Some of the kinases responsible for this increased phosphorylation are MLCK, PKC, and CaM kinase II. However, increased phosphorylation can also be induced by the altered activity of a phosphatase, yet there is little information about the serine/threonine phosphatases that regulate myosin function during exocytosis in any cell. Herein, we demonstrate for the first time that after mast cell stimulation, both the major serine/threonine phosphatases, PP1 and PP2A, associate with myosin and play a major role in regulating the cytoskeletal remodeling
Our data clearly demonstrate that after activation, PP1 and PP2A are
relocated from a diffuse distribution throughout the cytoplasm to
regions of the cell where actin and myosin have become concentrated.
Recent work has shown that the apical ruffles formed in activated
RBL-2H3 cells also contain PLC
1 (Barker et al., 1998
),
suggesting that they are a locus of high cellular signaling activity
during the secretory process. The dynamic nature of these changes is
demonstrated in the time course of the redistribution of PP1 and PP2A
after stimulation, which coincides or indeed precedes the time of peak
release of granule mediators (Ludowyke et al., 2000
). This
correlation is also apparent in the slower, more prolonged response to
PMA plus A23187, due to the prolonged activation of PKC by phorbol
esters. Because actin and myosin are similarly redistributed, it is
feasible that PP1 and PP2A contribute to these cytoskeletal rearrangements.
The interaction between actin and myosin is primarily regulated by
phosphorylation. It is clear that in vitro or in living cells, PP1 can
associate with and dephosphorylate the myosin light chain and affect
actin microfilaments (Chisholm and Cohen, 1988
; Fernandez et
al., 1990
). In unstimulated RBL-2H3 cells, both PP1 and PP2A
associate with myosin and after stimulation this level of association
is significantly increased. Remarkably, this increased association is
transient, coinciding with the peak rate of secretion, and as the rate
of secretion diminished, so too did the association of the phosphatases
with myosin. This suggests there is an active mechanism for
attachment and removal of the phosphatases from the myosin complex. In
our previous study, we described the transient translocation of
phosphatases to the plasma membrane of RBL-2H3 cells, again peaking at
2.5 min (Ludowyke et al., 2000
). However, in that instance
only PP2A was translocated to the plasma membrane; PP1 was not.
Therefore, although both PP1 and PP2A contribute to the cytoskeletal
changes required for secretion, only PP2A is involved in the secretory
events at the plasma membrane.
Jasplakinolide binds to and stabilizes F-actin, limiting the amount of
monomeric actin available for remodeling of stress fibers (Bubb
et al., 2000
). We have recently demonstrated that jasplakinolide inhibits insulin secretion from RINm5F cells (Wilson et al., 2001
). In the present study jasplakinolide inhibited
secretion from mast cells and prevented the cytoskeletal rearrangement
of actin, PP1, and PP2A seen after antigen stimulation. Surprisingly, jasplakinolide also had a dramatic effect on myosin, inducing the
formation of short rods, spread throughout the cytoplasm. This
distribution was unaffected by antigen stimulation. To our knowledge,
this is the first time such an effect of jasplakinolide on myosin has
been described. Interestingly, jasplakinolide did not affect the
association of myosin with PP1, PP2A, or actin, before or after
stimulation. Therefore, inhibition of secretion by jasplakinolide can
be interpreted as evidence of the requirement for a dynamic actomyosin
interaction in the secretory process.
Addition of OA to RBL-2H3 cells induced changes in the association of
both PP1 and PP2A with myosin and inhibited the activated cytoskeletal
changes. However, in RBL-2H3 cells, under these conditions, OA only
inhibits the activity of PP2A, suggesting that PP2A has the predominant
role in these cytoskeletal changes and may also effect the association
of PP1 with myosin. PP2A is the major phosphatase acting on caldesmon,
a protein that blocks the interaction of actin with myosin (Ferrigno
et al., 1993
). Furthermore, in fibroblasts, dephosphorylation of the intermediate filament protein vimentin has
been shown to be controlled by PP2A and not PP1 (Turowski et
al., 1999
) and the addition of OA to RBL-2H3 cells leads to increased vimentin phosphorylation (Ludowyke et al., 1998
).
Therefore, it is likely that dynamic changes in the phosphorylation
state of several cytoskeletal proteins are regulated by PP2A (Sontag, 2001
). Our present finding that PP2A associates with myosin during mast
cell secretion was, however, surprising, because only PP1 has been
implicated in the regulation of myosin through MLC phosphorylation (Chisholm and Cohen, 1988
; Hartshorne et al., 1998
).
However, recent studies in Dictyostelium have implicated
PP2A as the regulatory phosphatase controlling myosin heavy chain
phosphorylation at sites that regulate myosin filament assembly (Murphy
and Egelhoff, 1999
). In RBL-2H3 cells, we and others have shown that
activation induces the phosphorylation of the MHC by PKC and CaM kinase
II. These sites are close to the carboxy terminus at the end of the coiled-coil region and are believed to contribute to the rearrangement of the actomyosin cytoskeleton that occurs during the secretory process
(Ludowyke et al., 1989
; Buxton and Adelstein, 2000
). In unstimulated RBL-2H3 cells the MLC is phosphorylated at a specific site
(Ser-19) that is regulated by MLCK and PP1, but phosphorylation at this
site does not change after activation. However, activation leads to a
significant increased phosphorylation at specific sites (Ser-1/Ser-2)
that are the major physiological sites for PKC (Ludowyke et
al., 1989
, 1996
; Choi et al., 1994
). The phosphatase
that regulates phosphorylation at these PKC sites is unknown, but our
present data implies that the major phosphatase involved is PP2A. The addition of OA under conditions that inhibit only PP2A and not PP1
induces little alteration in the phosphorylation of the MLC sites
regulated by MLCK and PP1, but a significant increase in the
phosphorylation of sites regulated by PKC. Therefore, our findings
suggest that PKC and PP2A together may be involved in regulating the
phosphorylation of the MHC at Ser-1917 and the MLC at Ser-1/Ser-2 that
occurs during mast cell secretion.
Although there is no evidence for OA-mediated activation of PKC, the increased phosphorylation at PKC-specific sites on myosin may occur in a number of ways. The inhibition of PP2A may lead to the stimulation of an upstream activator of PKC or the removal of an inhibitory binding protein. Alternatively, the unstimulated activity of PKC for myosin may always be high, yet the level of MHC or MLC phosphorylation is kept low by a much greater activity of PP2A. Thus, inhibiting the activity of PP2A leads to increased phosphorylation due to the high level of unstimulated PKC activity. Although these are important questions, the major impact of the results presented herein is that PP2A is identified as playing an important role in regulating the phosphorylation and thus the function of myosin during mast cell secretion.
In the larger context, a question arises as to what functional role
these changes have in the mast cell exocytotic process. Notably, in the
area of the cytoplasm between the nucleus and the cell periphery, there
was a significant decrease in the levels of PP1 and PP2A (3.2-fold) and
myosin (5-fold). This "clearance" of the actomyosin cytoskeleton
from this region may be an important mechanism to allow granules easier
access to the plasma membrane. We propose that the formation of the
peripheral band pulls at the cortical barrier from one direction
(toward the periphery), and the formation of the apical ruffles pulls
the barrier back toward the center of the cell or at least in an
opposing direction, thus "stretching" the cortical web in the
region between the nucleus and cell periphery. As the cells spread out
by ~50% (Ludowyke et al., 1994a
,b
), this region, which
has a smaller distance between the apical and basal surfaces, also has
a diminished concentration of actomyosin, which may allow the granules
easier access to the plasma membrane, without requiring a major
disassembly of the cortical barrier.
In summary, stimulation of RBL-2H3 cells induces a transient association of the serine/threonine phosphatases PP1 and PP2A with myosin, which coincides with the peak rate of granule mediator release. This association is likely to be linked with the transient but significant clearance of actomyosin from the cytoplasm between the cell periphery and the nucleus, into ruffles on the apical surface and a band at the periphery of the cell. This remodeling coincides with or precedes the peak rate of mediator release. Inhibitors of either phosphatase activity or actin assembly inhibit both exocytosis and this cytoskeletal remodeling and give evidence of the interaction of PKC and PP2A in regulating myosin phosphorylation. Overall, our studies indicate that exocytosis does require a dynamic actomyosin microfilament system and that PP1 and PP2A play a stimulatory role in these events.
| |
ACKNOWLEDGMENTS |
|---|
We thank Prof. Keith Stanley for critical reading of the manuscript and suggestions for data analysis, and Dr. Trevor Biden for critical reading of the manuscript. This work was supported by grants from The Community Health and Anti-Tuberculosis Association, The Asthma Foundation of New South Wales, The National Health and Medical Research Council of Australia, and was partially funded by a New South Wales health research and development infrastructure grant. R.I.L. is supported by the Sternberg Research Fellowship.
| |
FOOTNOTES |
|---|
Corresponding author. E-mail address:
r.ludowyke{at}cfi.unsw.edu.au.
Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.01-12-0587. Article and publication date are at www.molbiolcell.org/cgi/10.1091/mbc.01-12-0587.
| |
ABBREVIATIONS |
|---|
Abbreviations used: DNP-BSA, antigen containing 24 molecules of dinitrophenol (DNP) conjugated with 1 molecule of bovine serum albumin (BSA); FITC, fluorescein isothiocyanate; IEF, isoelectric focusing; MHC, myosin heavy chain; MLC, myosin light chain; MLCK, myosin light chain kinase; OA, okadaic acid; PBS, phosphate-buffered saline; PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; PP1 or PP2A, protein phosphatase type 1 or type 2A.
| |
REFERENCES |
|---|
|
|
|---|